Schonfeld Strategic Advisors’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $855K | Sell |
|
|||||
|
2024
Q2 | $1.88M | Sell |
|
|||||
|
2024
Q1 | $2.54M | Sell |
|
|||||
|
2023
Q4 | $3.26M | Sell |
|
|||||
|
2023
Q3 | $1.21M | Sell |
|
|||||
|
2023
Q2 | $1.83M | Sell |
|
|||||
|
2023
Q1 | $2.88M | Buy |
|
|||||
|
2022
Q4 | $4.4M | Sell |
|
|||||
|
2022
Q3 | $5.38M | Buy |
|
|||||
|
2022
Q2 | $382K | Sell |
|
|||||
|
2022
Q1 | $496K | Sell |
|
|||||
|
2021
Q4 | $1.45M | Buy |
|
|||||
|
2021
Q3 | $166K | Sell |
|
|||||
|
2021
Q2 | $1.27M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $6.67M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $215K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $278K | Buy |
|